Effects of 'SPRAT' programme for dietary and lifestyle education to improve psychosomatic symptoms and dietary habits among adolescents: a cluster randomised controlled trial.
Adolescents
Cluster randomisation
Effectiveness
Lifestyle modification
School-based
Subjective psychosomatic symptoms
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
08 03 2022
08 03 2022
Historique:
received:
30
09
2021
accepted:
22
02
2022
entrez:
8
3
2022
pubmed:
9
3
2022
medline:
10
5
2022
Statut:
epublish
Résumé
Dietary and lifestyle modifications to reduce subjective psychosomatic symptoms (SPS) have become an important topic worldwide. We developed a school-based dietary and lifestyle education programme that involved parents/guardians in reducing SPS in adolescents (SPRAT). The programme encouraged parents/guardians to participate in adolescents' healthy dietary and lifestyle modifications to reduce SPS, increase enjoyment of school life, and foster appropriate dietary intake. This study evaluated the effectiveness of SPRAT in reducing SPS and in altering dietary behaviour among adolescents. A 6-month cluster randomised controlled trial using SPRAT and the usual school programme (control) was performed. Participants were middle school students in Japan who provided informed consent. Outcomes were SPS scores assessed at baseline and 2, 4, and 6 months after baseline and the proportions of dietary and lifestyle factors achieved such as enjoyment of school life and dietary intakes assessed by FFQW82. Change from baseline (CFB) at 6 months was the primary endpoint. A linear mixed-effects model was applied. As for dietary intake, the treatment effect was estimated as an interaction term between baseline and treatment "baseline*treatment". The intention-to treat analysis included 951 (94.7%) and 1035 (89.8%) individuals in the SPRAT and control groups, respectively. The CFB in the 6-month SPS score adjusted for baseline was lower in the SPRAT group (-0.29) than in the control group (0.62), but the difference was not statistically significant -0.91 (p = 0.093). Although the primary endpoint tended to denote improvement in the SPRAT group compared to the control group, the improvement was not significant. Favourable effects were observed in some secondary outcomes and statistically significant treatment*baseline interactions were observed for several dietary intakes. These results imply that CFBs of dietary intake were increased or decreased in a favourable direction depending on the baseline intake, especially in the SPRAT group. UMIN000026715. (27/03/2017).
Sections du résumé
BACKGROUND
Dietary and lifestyle modifications to reduce subjective psychosomatic symptoms (SPS) have become an important topic worldwide. We developed a school-based dietary and lifestyle education programme that involved parents/guardians in reducing SPS in adolescents (SPRAT). The programme encouraged parents/guardians to participate in adolescents' healthy dietary and lifestyle modifications to reduce SPS, increase enjoyment of school life, and foster appropriate dietary intake. This study evaluated the effectiveness of SPRAT in reducing SPS and in altering dietary behaviour among adolescents.
METHODS
A 6-month cluster randomised controlled trial using SPRAT and the usual school programme (control) was performed. Participants were middle school students in Japan who provided informed consent. Outcomes were SPS scores assessed at baseline and 2, 4, and 6 months after baseline and the proportions of dietary and lifestyle factors achieved such as enjoyment of school life and dietary intakes assessed by FFQW82. Change from baseline (CFB) at 6 months was the primary endpoint. A linear mixed-effects model was applied. As for dietary intake, the treatment effect was estimated as an interaction term between baseline and treatment "baseline*treatment".
RESULTS
The intention-to treat analysis included 951 (94.7%) and 1035 (89.8%) individuals in the SPRAT and control groups, respectively. The CFB in the 6-month SPS score adjusted for baseline was lower in the SPRAT group (-0.29) than in the control group (0.62), but the difference was not statistically significant -0.91 (p = 0.093).
CONCLUSIONS
Although the primary endpoint tended to denote improvement in the SPRAT group compared to the control group, the improvement was not significant. Favourable effects were observed in some secondary outcomes and statistically significant treatment*baseline interactions were observed for several dietary intakes. These results imply that CFBs of dietary intake were increased or decreased in a favourable direction depending on the baseline intake, especially in the SPRAT group.
TRIAL REGISTRATION
UMIN000026715. (27/03/2017).
Identifiants
pubmed: 35255866
doi: 10.1186/s12889-022-12832-7
pii: 10.1186/s12889-022-12832-7
pmc: PMC8903559
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
461Informations de copyright
© 2022. The Author(s).
Références
Stat Med. 2011 Feb 20;30(4):377-99
pubmed: 21225900
PLoS One. 2016 Oct 25;11(10):e0165285
pubmed: 27780251
News Physiol Sci. 2001 Apr;16:71-6
pubmed: 11390952
BMJ. 2015 Sep 14;351:h4119
pubmed: 26371214
BMJ. 2004 May 22;328(7450):1237
pubmed: 15107313
Cochrane Database Syst Rev. 2014 Apr 16;(4):CD008958
pubmed: 24737131
Lancet. 2011 Oct 22;378(9801):1515-25
pubmed: 22008427
Am J Clin Nutr. 2003 Nov;78(5):1030-8
pubmed: 14594792
Aust N Z J Psychiatry. 2014 Jul;48(7):606-16
pubmed: 24829198
Am J Prev Med. 2012 Mar;42(3):327-8
pubmed: 22341171
BMJ Open. 2018 Feb 16;8(2):e018938
pubmed: 29453300
Am J Prev Med. 2013 Oct;45(4):407-15
pubmed: 24050416
Int J Public Health. 2012 Aug;57(4):673-8
pubmed: 22301709
Int J Qual Stud Health Well-being. 2015 Aug 14;10:27397
pubmed: 26282870
Clin Psychol Rev. 2016 Apr;45:56-71
pubmed: 27064552
Am J Public Health. 2014 Oct;104(10):e31-42
pubmed: 25208008
BMJ Open. 2011 Dec 12;1(2):e000252
pubmed: 22155938
Biopsychosoc Med. 2012 Mar 20;6:6
pubmed: 22433184
J Pediatr Psychol. 2014 Sep;39(8):809-25
pubmed: 24824614
Psychoneuroendocrinology. 2008 May;33(4):517-29
pubmed: 18337016
BMC Public Health. 2019 Jul 23;19(1):980
pubmed: 31337374
Br J Sports Med. 2016 Apr;50(8):488-95
pubmed: 26359346
J Sch Health. 2013 Nov;83(11):763-70
pubmed: 24138346
Obes Rev. 2011 Mar;12(3):205-16
pubmed: 20122137
Br J Sports Med. 2014 May;48(9):768-73
pubmed: 23624466
BMJ. 2012 Sep 27;345:e5888
pubmed: 23044984
Health Psychol. 2010 Jan;29(1):91-101
pubmed: 20063940
Maturitas. 2011 Nov;70(3):266-84
pubmed: 21920682
Nihon Koshu Eisei Zasshi. 2010 Jun;57(6):475-85
pubmed: 20718205
Public Health Nutr. 2011 Apr;14(4):702-8
pubmed: 20843402
BMJ. 2014 May 27;348:g3256
pubmed: 24865166
N Engl J Med. 2019 Jul 18;381(3):285-286
pubmed: 31314974
J Am Diet Assoc. 2005 May;105(5):743-60; quiz 761-2
pubmed: 15883552
J Pediatr Health Care. 2006 Nov-Dec;20(6):401-6
pubmed: 17071371
BMJ. 2004 Mar 20;328(7441):702-8
pubmed: 15031246
Health Educ Res. 2013 Jun;28(3):523-38
pubmed: 23515117
Environ Health Prev Med. 2004 May;9(3):95-102
pubmed: 21432317